The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting

Affiliations

• ¹ Clinical Pharmacology and Toxicology Research Unit, Department of Pharmacy, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Namur, Belgium.
• ² Vascular Medicine, Department of Medicine. NorthShore University HealthSystem, Evanston, IL, USA; University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.
• ³ Vascular Medicine, Department of Medicine. NorthShore University HealthSystem, Evanston, IL, USA.
• ⁴ Clinical Pharmacology and Toxicology Research Unit, Department of Pharmacy, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Namur, Belgium; QUALIblood s.a., QUALIresearch, Namur, Belgium.
• ⁵ Cardiovascular Research Institute, Stritch School of Medicine, Health Sciences Division, Loyola University Chicago, Maywood, IL, USA.
• ⁶ Heidelberg University, Heidelberg, Germany; DOASENSE, GmbH, Heidelberg, Germany.
• ⁷ Clinical Pharmacology and Toxicology Research Unit, Department of Pharmacy, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Namur, Belgium; QUALIblood s.a., QUALIresearch, Namur, Belgium; Department of Biological Hematology, CHU Clermont-Ferrand, Hôpital Estaing, France. Electronic address: [email protected].